Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Carcinoma, Basal Cell, Pigmented

fluorodeoxyglucose f18 has been researched along with Carcinoma, Basal Cell, Pigmented in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Bachmann, IM; Haslerud, TM; Helgeland, L; Karlsdottir, Å; Reikvam, H; Thunestvedt, LMØ	1
In, GK; Jadvar, H	1
Klinghuber, M; Müller, G; Pabst, A; Vandersee, S; Werkmeister, R	1
Dong, A; Lu, J; Wang, Y; Zuo, C	1
Azuma, H; Ibuki, N; Inamoto, T; Katsuoka, Y; Komura, K; Koyama, K; Tsuji, M; Ubai, T	1
Baldwin, J; Blaydorn, L; Downhour, M; Hoff, DD; Korn, RL; Thacker, CA; Tibes, R; Weiss, GJ; White, E	1
Cook, TF; Fosko, SW; Hu, W; Lowe, VJ	1
Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M	1
Gamie, SH; Niederkohr, RD	1
Endo, K; Inoue, T; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Takeuchi, K	1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Basal Cell, Pigmented

Article	Year
Positron emission tomography for basal cell carcinoma of the head and neck. Archives of dermatology, 2003, Volume: 139, Issue:9 Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed	2003

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Basal Cell, Pigmented

Article	Year
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib. Cancer medicine, 2012, Volume: 1, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2012

Article

Year

18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.

Cancer medicine, 2012, Volume: 1, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2012

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Basal Cell, Pigmented

Article	Year
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis. Current oncology (Toronto, Ont.), 2022, 03-23, Volume: 29, Issue:4 Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms	2022
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. Clinical nuclear medicine, 2021, Aug-01, Volume: 46, Issue:8 Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Hedgehog Proteins; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Signal Transduction; Skin Neoplasms; Treatment Outcome	2021
Extensive bony metastases from facial metatypical basal cell carcinoma: a case report. The British journal of oral & maxillofacial surgery, 2019, Volume: 57, Issue:1 Topics: Adult; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms	2019
MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma. International journal of clinical oncology, 2010, Volume: 15, Issue:6 Topics: Aged; Biomarkers, Tumor; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Male; Positron-Emission Tomography; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms	2005
F-18 FDG PET as an imaging tool for detecting and staging metastatic basal-cell carcinoma. Clinical nuclear medicine, 2007, Volume: 32, Issue:6 Topics: Carcinoma, Basal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Whole Body Imaging	2007
The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. Annals of nuclear medicine, 2001, Volume: 15, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	2001